Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2014 Feb;20(2):149-53.
doi: 10.1016/j.bbmt.2013.11.006. Epub 2013 Nov 12.

Blood and Marrow Transplant Clinical Trials Network: progress since the State of the Science Symposium 2007

James L M Ferrara  1
Affiliations
Editorial

Blood and Marrow Transplant Clinical Trials Network: progress since the State of the Science Symposium 2007

James L M Ferrara. Biol Blood Marrow Transplant. 2014 Feb.

Abstract

Outcomes of hematopoietic cell transplantation continue to improve. New techniques have reduced transplant toxicities, and there are new sources of hematopoietic stem cells from related and unrelated donors. In June 2007, the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) convened a State of the Science Symposium (SOSS) in Ann Arbor and identified 11 high priority clinical trials for the network to pursue. This article reviews both the status of those trials and the record of achievement of the BMT CTN as it convenes another SOSS in Grapevine, Texas in February 2014.

Keywords: Acute lymphocytic leukemia; Acute myeloid leukemia; Biomarkers; Cell therapy; Chronic lymphocytic leukemia; Clinical Trials Network; Clinical trials; Crohn's disease; Graft-versus-host disease; Hemaphogocytic lymphohistiocytosis; Hematopoietic cell transplantation; Quality of life; T cell lymphoma.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement: There are no conflicts of interest to disclose.

References

    1. Beschorner WE, Suresch DL, Shinozawa T, et al. Thymic immunopathology after cyclosporine: effect of irradiation and age on medullary involution and recovery. Transplant Proc. 1988;20:1072–1078. - PubMed
    1. Shinozawa T, Beschorner WE, Hess AD. The thymus and prolonged administration of cyclosporine. Transplant. 1990;50:106–111. - PubMed
    1. Kansu E, Gooley T, Flowers ME, et al. Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial. Blood. 2001;98:3868–3870. - PubMed
    1. Beschorner WE, Hess AD, Shinn CA, et al. Transfer of cyclosporine-associated syngeneic graft-versus-host disease by thymocytes. Resemblance to chronic graft-versus-host disease. Transplantation. 1988;45:209–215. - PubMed
    1. Santos GW, Hess AD, Vogelsang GB. Graft-versus-host reactions and disease. Immunol Rev. 1985;88:169–192. - PubMed